Guardian Pharmacy Company Leadership
| GRDN Stock | 24.94 0.02 0.08% |
Guardian Pharmacy's insiders are aggressively buying. The analysis of current insiders' outlook of investing in Guardian Pharmacy Services, suggests that virtually all insiders are extremely bullish regarding Guardian Pharmacy's prospects. Guardian Pharmacy employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive.
Guardian Pharmacy's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2024-11-19 | Steven D Cosler | Acquired 7000 @ 21.22 | View | ||
| 2024-09-27 | Thomas J Salentine Jr | Acquired 35714 @ 14 | View |
Monitoring Guardian Pharmacy's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Guardian |
Guardian Pharmacy Management Team Effectiveness
At this time, Guardian Pharmacy's Non Current Assets Total are very stable compared to the past year. As of the 1st of December 2024, Non Currrent Assets Other is likely to grow to about 365.4 K, while Total Assets are likely to drop about 269.8 M. Guardian Pharmacy's management efficiency ratios could be used to measure how well Guardian Pharmacy manages its routine affairs as well as how well it operates its assets and liabilities.Guardian Pharmacy Quarterly Income Before Tax |
|
Guardian Pharmacy Workforce Comparison
Guardian Pharmacy Services, is currently under evaluation in number of employees category among its peers. The total workforce of Medical Care Facilities industry is currently estimated at about 27,104. Guardian Pharmacy adds roughly 0.0 in number of employees claiming only tiny portion of all equities under Medical Care Facilities industry.
Guardian Pharmacy Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of fourty-seven. Guardian Pharmacy Price Series Summation is a cross summation of Guardian Pharmacy price series and its benchmark/peer.
Guardian Pharmacy Notable Stakeholders
A Guardian Pharmacy stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Guardian Pharmacy often face trade-offs trying to please all of them. Guardian Pharmacy's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Guardian Pharmacy's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Fred Burke | President CEO | Profile | |
| Brian Rosati | President Daytona | Profile | |
| Rockford Anderson | President Iowa | Profile | |
| Robin Smith | President Services | Profile | |
| David Morris | Executive CFO | Profile | |
| Douglas Towns | VP Counsel | Profile | |
| David Martin | Vice Officer | Profile | |
| Bethany RPh | Senior Marketing | Profile | |
| Kendall RPh | Executive Operations | Profile | |
| Vicki Crabtree | Vice Resources | Profile |
About Guardian Pharmacy Management Performance
The success or failure of an entity such as Guardian Pharmacy often depends on how effective the management is. Guardian Pharmacy management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Guardian management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Guardian management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Guardian Pharmacy is entity of United States. It is traded as Stock on NYSE exchange.
Guardian Pharmacy Workforce Analysis
Traditionally, organizations such as Guardian Pharmacy use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Guardian Pharmacy within its industry.Guardian Pharmacy Manpower Efficiency
Return on Guardian Pharmacy Manpower
| Revenue Per Employee | 104.6M | |
| Revenue Per Executive | 104.6M | |
| Net Income Per Employee | 2.4M | |
| Net Income Per Executive | 2.4M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.